Proceedings of the International symposium on Sustainable Drug Design and Nanoparticle development: Quantum and Computational Perspectives (SDDNDQCP 2025)

<Previous Article In Volume
Next Article In Volume>

A Study on Evaluation of Quality of Life among Epileptic Patients and the Impact of Clinical Pharmacist in Improving the Quality of Life

Authors
R. Narasimha Naik1, Mallela Maharshi2, M. Neha Sri2, *, S. K. Shahina Begam2, P. Sajida2, Ch Sai Lokendra2
1Department of Pharmacology, Dattakala Institute of Pharmaceutical Sciences and Research (For Girls), Swami Chincholi, Bhigwan, Pune, Maharashtra, India
2Department of Pharmacology and Pharmacy Practice, Nirmala College of Pharmacy, Atmakur, Mangalagiri, Guntur, Andhra Pradesh, India
*Corresponding author. Email: nehasrimungamuri@gmail.com
Corresponding Author
M. Neha Sri
Available Online 13 August 2025.
DOI
10.2991/978-94-6463-813-4_19How to use a DOI?
Keywords
Epilepsy; Quality of life; Neurological disorders; Seizure frequency; Neurological functioning; People with epilepsy
Abstract

Epilepsy exists as a common neuropsycological condition marked with frequent spontaneous convulsive attacks. Sometimes accompanied by unconsciousness. It is anticipated to have an impact on 50 million of individuals globally. The present investigation aims towards the evaluation of Quality of life in those who have epilepsy, considering various factors such as seizure frequency, medication, psychological well-being and social functioning. The QOL of 200 individuals with epilepsy was evaluated in a prospective observational research, carried out in a tertiary care hospital using the standard QOLIE-31 scale. The sum of 200 PWE, their QOL evaluated. Nearly 62.5% of patients reveal they had a good quality of life, while about 23% had mixed experiences. Findings reveal that male were slightly higher chance than female to have epilepsy. The age group most impacted by epilepsy was 30 - 40 years old. About one-fourth of patients said they had slight memory problems, and 15.5% reveals they occasionally had memory problems. The study shows that to accommodate the special demands of epileptic residents especially men also those between the ages of 30–40 underscores the holistic management strategies to enhance QOL in epileptic patients.

Copyright
© 2025 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the International symposium on Sustainable Drug Design and Nanoparticle development: Quantum and Computational Perspectives (SDDNDQCP 2025)
Series
Advances in Health Sciences Research
Publication Date
13 August 2025
ISBN
978-94-6463-813-4
ISSN
2468-5739
DOI
10.2991/978-94-6463-813-4_19How to use a DOI?
Copyright
© 2025 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

risenwbib
TY  - CONF
AU  - R. Narasimha Naik
AU  - Mallela Maharshi
AU  - M. Neha Sri
AU  - S. K. Shahina Begam
AU  - P. Sajida
AU  - Ch Sai Lokendra
PY  - 2025
DA  - 2025/08/13
TI  - A Study on Evaluation of Quality of Life among Epileptic Patients and the Impact of Clinical Pharmacist in Improving the Quality of Life
BT  - Proceedings of the International symposium on Sustainable Drug Design and Nanoparticle development: Quantum and Computational Perspectives (SDDNDQCP 2025)
PB  - Atlantis Press
SP  - 259
EP  - 266
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-813-4_19
DO  - 10.2991/978-94-6463-813-4_19
ID  - Naik2025
ER  -